MINSHENG ROYAL FUND MANAGEMENT CO BIOTECHNOLOGY ETF CNYMINSHENG ROYAL FUND MANAGEMENT CO BIOTECHNOLOGY ETF CNYMINSHENG ROYAL FUND MANAGEMENT CO BIOTECHNOLOGY ETF CNY

MINSHENG ROYAL FUND MANAGEMENT CO BIOTECHNOLOGY ETF CNY

No trades
See on Supercharts

Key stats


Assets under management (AUM)
Fund flows (1Y)
Dividend yield (indicated)
Discount/Premium to NAV
Shares outstanding
Expense ratio
0.60%

About MINSHENG ROYAL FUND MANAGEMENT CO BIOTECHNOLOGY ETF CNY


Issuer
Minsheng Royal Fund Management Co., Ltd.
Brand
Minsheng Royal
Inception date
Aug 5, 2021
Structure
Open-Ended Fund
Index tracked
CSI Biotechnology Theme Index - CNY - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Minsheng Royal Fund Management Co., Ltd.
ISIN
CNE100004X99
Closely track the target index, pursue the minimization of tracking deviation and tracking err, and strive to achieve Long-term investment income consistent with the performance of the underlying index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
2%97%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to 516930 via country, focus, and more.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
516930 trades at 0.496 CNY today, its price has fallen −1.78% in the past 24 hours. Track more dynamics on 516930 price chart.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
516930 invests in stocks. See more details in our Analysis section.
516930 expense ratio is 0.60%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 516930 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 516930 technical analysis shows the buy rating and its 1-week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 516930 shows the buy signal. See more of 516930 technicals for a more comprehensive analysis.
No, 516930 doesn't pay dividends to its holders.
516930 shares are issued by Minsheng Royal Fund Management Co., Ltd.
516930 follows the CSI Biotechnology Theme Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Aug 5, 2021.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.